Companies / Mineralys Therapeutics Inc / Activity
Activity — Mineralys Therapeutics Inc
100 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Gold Alexander M Director | Grant | Common Stock | $0 | +6K | 6,200 <0.01% of shares | low |
| Feb 19, 2026 | Slingsby Brian Taylor Director | Other | Common Stock | $0 | +6K +0.08% | 7,910,038 8.95% of shares | low |
| Feb 19, 2026 | Slingsby Brian Taylor Director | Other | Common Stock | $0 | -6K -100.00% | 0 0.00% of shares | low |
| Feb 19, 2026 | Slingsby Brian Taylor Director | Grant | Common Stock | $0 | +6K | 6,200 <0.01% of shares | low |
| Feb 19, 2026 | Karydas Daphne Director | Grant | Common Stock | $0 | +6K | 6,200 <0.01% of shares | low |
| Feb 19, 2026 | DiRocco Derek Director | Grant | Common Stock | $0 | +6K | 6,200 <0.01% of shares | low |
| Feb 19, 2026 | Levy Adam Scott Executive | Grant | Common Stock | $0 | +40K +461.91% | 48,538 0.05% of shares | low |
| Feb 19, 2026 | Rodman David Malcom Executive | Grant | Common Stock | $0 | +38K +87.10% | 82,489 0.09% of shares | low |
| Feb 19, 2026 | Congleton Jon CEO | Grant | Common Stock | $0 | +141K +22.04% | 780,051 0.88% of shares | low |
| Feb 19, 2026 | RA Capital Management, L.P. Director | Grant | Common Stock | $0 | +6K | 6,200 <0.01% of shares | low |
| Feb 19, 2026 | Sblendorio Glenn Director | Grant | Common Stock | $0 | +6K | 6,200 <0.01% of shares | low |
| Feb 19, 2026 | Akkaraju Srinivas Director | Grant | Common Stock | $0 | +6K | 6,200 <0.01% of shares | low |
| Jan 20, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $6.4K | +416 +0.82% | 50,853 0.06% of shares | low |
| Mar 17, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $6.4K | +417 +0.55% | 76,557 0.09% of shares | low |
| Feb 17, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $6.4K | +417 +0.95% | 44,506 0.05% of shares | low |
| Mar 12, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $6.9K | +6K +7.70% | 88,837 0.10% of shares | low |
| Jan 12, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $6.9K | +6K +10.27% | 68,152 0.08% of shares | low |
| Feb 12, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $6.9K | +6K +12.59% | 56,786 0.06% of shares | low |
| Mar 13, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $7.0K | -253 -0.33% | 76,140 0.09% of shares | low |
| Mar 17, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $10.7K | -417 -0.54% | 76,140 0.09% of shares | low |
| Jan 2, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $10.9K | +10K +13.99% | 81,888 0.09% of shares | low |
| Feb 17, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $11.5K | -417 -0.94% | 44,089 0.05% of shares | low |
| Jan 20, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $13.4K | -416 -0.82% | 50,437 0.06% of shares | low |
| Feb 12, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $15.4K | -521 -1.02% | 50,437 0.06% of shares | low |
| Jan 5, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $30.3K | +28K +40.52% | 97,226 0.11% of shares | low |
| Jan 9, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $34.7K | +2K +3.51% | 63,974 0.07% of shares | low |
| Mar 9, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $34.7K | +2K +2.63% | 84,660 0.10% of shares | low |
| Feb 9, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $34.7K | +2K +4.30% | 52,608 0.06% of shares | low |
| Feb 13, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $36.1K | +4K +7.02% | 53,978 0.06% of shares | low |
| Mar 13, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $36.1K | +4K +4.29% | 86,031 0.10% of shares | low |
| Jan 13, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $36.1K | +4K +5.73% | 65,346 0.07% of shares | low |
| Jan 2, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $56.0K | +4K +4.43% | 85,517 0.10% of shares | low |
| Mar 9, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $58.3K | -2K -2.56% | 82,489 0.09% of shares | low |
| Feb 13, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $59.4K | +4K +8.26% | 54,603 0.06% of shares | low |
| Mar 13, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $59.4K | +4K +4.84% | 90,198 0.10% of shares | low |
| Jan 13, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $59.4K | +4K +6.38% | 69,513 0.08% of shares | low |
| Feb 9, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $65.6K | -2K -4.13% | 50,437 0.06% of shares | low |
| Jan 9, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $72.2K | -2K -3.39% | 61,804 0.07% of shares | low |
| Mar 13, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $84.3K | -3K -3.87% | 76,393 0.09% of shares | low |
| Jan 2, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $95.3K | +9K +10.93% | 94,864 0.11% of shares | low |
| Feb 13, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $96.8K | -4K -6.56% | 50,437 0.06% of shares | low |
| Feb 13, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $113.9K | -4K -7.63% | 50,437 0.06% of shares | medium |
| Jan 5, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $156.3K | +10K +10.41% | 107,347 0.12% of shares | low |
| Feb 12, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $168.6K | -6K -10.26% | 50,958 0.06% of shares | medium |
| Mar 12, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $173.7K | -6K -7.15% | 82,489 0.09% of shares | medium |
| Feb 13, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $175.1K | -6K -12.59% | 44,089 0.05% of shares | medium |
| Jan 12, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $205.1K | -6K -9.31% | 61,804 0.07% of shares | medium |
| Jan 12, 2026 | Congleton Jon CEO | Sell | Common Stock | $235.9K | -7K -1.10% | 639,151 0.72% of shares | medium |
| Jan 13, 2026 | Rodman David Malcom Executive | Sell | Common Stock | $252.5K | -8K -11.09% | 61,804 0.07% of shares | medium |
| Jan 5, 2026 | Rodman David Malcom Executive | Exercise | Common Stock | $265.9K | +26K +24.28% | 133,416 0.15% of shares | low |